Skip to main content

Table 1 Medical history and cancer cases of patients positive for NSp-II antibodies

From: Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay

Group/

NSp-II signal in IIF

Time delay in months

Registered cancer cases

Additional medical history

sample ID

Topography/histology

Diagnosis

Invasive cancer

    

PS 1

Strong

 

Lung, small cell carcinoma

 

PS 2.1

Strong

0

Cervix uteri, carcinoma in situ

Systemic lupus erythematosus

PS 2.2

Medium

26

  

PS 2.3

Medium

74

  

PS 2.4

Medium

97

  

PS 4

Medium

 

Breast, Infiltrating duct carcinoma

 

PS 6.1

Medium

0

Lung small cell carcinoma

Arthritis urica/Muscular rheumatism

PS 6.2

Strong

1

  

PS 8.1

Medium

0

Lung, adenocarcinoma

Eye, benign tumor

PS 8.2

Medium

1

  

PS 8.3

Medium

4

  

PS 9.1

Medium

0

Ovary, clear cell adenocarcinoma

Peritoneum and lymph node metastasis

PS 9.2

Medium

1

  

PS 9.3

Medium

10

  

PS 9.4

Medium

18

  

PS 12.1

Strong

0

Brain, unspecified tumor

Sjögren's syndrome/reumatoid arthritis

PS 12.2

Medium

25

  

PS 12.3

Strong

51

  

PS 12.4

Medium

53

  

PS 13

Medium

 

Base of tongue, squamous cell carcinoma

Carrier of Human T-lymphotrophic virus-1/Reactive arthritis

PS 15

Strong

 

Esophagus, Squamous cell carcinoma

Rheumatoid arthritis

PS 16

Medium

 

Breast, infiltrating duct carcinoma

Bone or bone marrow, metastasis /Lymph node malignant tumor

PS 17.1

Medium

0

Breast, infiltrating duct carcinoma

Septicaemia

PS 17.2

Strong

14

  

PS 17.3

Medium

59

  

PS 18

Medium

 

Unknown site, adenocarcinoma

Lung, malignant tumor

PS 23

Strong

 

Base of tongue, squamous cell carcinoma

Oropharynx, malignant tumor

PS 27

Strong

 

Lymph node, diffuse large cell lymphoma

 

Benign tumor

    

PS 3

Weak

  

Liver transplantation/Face, benign tumor

PS 19

Weak

  

Skin, benign tumor/Sjögren's syndrome

PS 21

Medium

  

Breast, benign cystic tumor

PS 24

Strong

  

Neoplasia-associated polyneuropathy

PS 25

Weak

  

Breast, benign tumor

No neoplasia

    

PS 5

Strong

  

Septicaemia

PS 7

Weak

   

PS 10

Weak

   

PS 11

Strong

  

Parkinson’s disease

PS 14

Medium

   

PS 20

Medium

   

PS 22

Weak

   

PS 26

Strong

   

PS 28

Medium

  Â